JIANG, JIAOYING – Trademark Portfolio
Entity Type: 01
JIANG, JIAOYING owns a portfolio of 7 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), including well-known marks such as BLSCODE, TUPOPAP, UF-BANS, and ASTRABASE. Of these, 4 are registered. The portfolio spans 5 Nice Classification classes, led by Class 8 (Hand Tools) and Class 10 (Medical Apparatus). Headquartered in JIANGXI PROVINCE.
NO.11 WANGJIA,BAIZI VILLAGE,
HUAQIAO TOWN, YUJIANG COUNTY, YINGTAN,
JIANGXI PROVINCE 335200 , CN
Showing of trademarks Trademarks
Trademark Classifications
JIANG, JIAOYING's trademark portfolio spans 5 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Common metals and their alloys; metal building materials; transportable buildings of metal
Games and playthings; gymnastic and sporting articles; decorations for Christmas trees
Frequently Asked Questions
How many trademarks does JIANG, JIAOYING have?
JIANG, JIAOYING has 7 U.S. trademarks filed with the USPTO. Of these, 4 registered, 1 abandoned, 2 cancelled.
What trademark classes does JIANG, JIAOYING file in?
JIANG, JIAOYING files trademarks across 5 Nice Classification classes. The most active classes are Class 8 (Hand Tools), Class 10 (Medical Apparatus), Class 9 (Computers & Electronics), Class 6 (Metal Goods), Class 28 (Toys & Sporting Goods). Class 8 covers hand tools and implements (hand-operated); cutlery; side arms; razors.
What are JIANG, JIAOYING's most well-known trademarks?
JIANG, JIAOYING's registered trademark portfolio includes well-known marks such as BLSCODE, TUPOPAP, UF-BANS, and ASTRABASE. These are among 4 currently registered trademarks in the portfolio.
What is JIANG, JIAOYING's trademark registration success rate?
JIANG, JIAOYING has a 57% trademark registration rate, with 4 out of 7 resolved applications resulting in successful registration. Currently, 0 applications are pending review.